Rainbow Coral Corp. (RBCC) Expands Focus in Booming $232 Billion Personalized Medicine Market
Today before the opening bell, Rainbow Coral announced that its biotech subsidiary, Rainbow BioSciences, will be targeting new innovations in the growing field of companion diagnostics. Ripe for expansion, the U.S. personalized medicine market is expected to grow to as much as $452 billion by 2015. Companion diagnostics is one of the fastest-growing fields in the market; it alone could total $42 billion in size by 2015, according to industry analysts TriMarkPublications.com. The key to ongoing rapid growth will be innovation. Companion diagnostics is the use of genetic variation to chart different patient responses to specific drugs or biologic agents…